Valued at $18 billion, medical robotics anticipates a staggering $83 billion market growth by 2032, fueled by adoption and improved outcomes.
AI seamlessly integrates into robotic platforms in 2024, offering enhanced navigation, real-time diagnosis, and the potential for autonomous procedures.
AI-driven implants and smart robotic arms signal momentum in soft robotics, especially for treating chronic conditions and navigating surgical sites.
Shrinking robotic platforms, including nanorobotics for in-body applications, hold immense promise for drug delivery and disease monitoring.
Mainstream telehealth, coupled with Metaverse innovations, enables telesurgery, transforming healthcare with remote robotic-assisted procedures for increased safety and accessibility.